Hims & Hers Health (NYSE:HIMS) experienced remarkable financial growth in Q1 2025, achieving a revenue of $586 million, an increase of 111% year-over-year. The company reported a net income of $49.5 million, up from $26 million in the previous quarter, and an Adjusted EBITDA of $91.1 million. Subscriber count grew by 38%, reaching 2.4 million. The company also updated its full-year 2025 revenue guidance and announced ambitious targets for 2030, aiming for at least $6.5 billion in revenue. CEO Andrew Dudum and CFO Yemi Okupe highlighted the focus on personalized care and strategic growth initiatives.
We're starting 2025 with incredible momentum. Millions of people are turning to us for access to care that is personal, affordable, and has the potential to drive better outcomes.
Revenue increased 111% year-over-year as we continued to deliver access to more precise, personalized care at scale. This momentum, combined with our strong track record of execution, reinforces our confidence in driving sustained long-term growth.
Collection
[
|
...
]